Khaled Abass

Dr. Khaled Abass

Arctic Health Team, University of Oulu, 90570 Oulu, Finland
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Environment International
Verified
Journal Article
Open access
AWAudrey Waits
Audrey Waits
Anastasia EmelyanovaAnastasia Emelyanova
Anastasia Emelyanova
AOAntti Oksanen
Antti Oksanen
Khaled AbassKhaled Abass
Khaled Abass
ARArja Rautio
Arja Rautio
Climatic factors, especially temperature, precipitation, and humidity play an important role in disease transmission. As the Arctic changes at an unprecedented rate due to climate change, understanding how climatic factors and climate change affect infectious disease rates is important for minimizing human and economic costs. The purpose of this systematic review was to compile recent studies in the field and compare the results to a previously published review. English language searches were conducted in PubMed, ScienceDirect, Scopus, and PLOS One. Russian language searches were conducted in the Scientific Electronic Library "eLibrary.ru". This systematic review yielded 22 articles (51%) published in English and 21 articles (49%) published in Russian since 2012. Articles about zoonotic and vector-borne diseases accounted for 67% (n = 29) of the review. Tick-borne diseases, tularemia, anthrax, and vibriosis were the most researched diseases likely to be impacted by climatic factors in the Arctic. Increased temperature and precipitation are predicted to have the greatest impact on infectious diseases in the Arctic.

1 February 2013 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
OPOlavi Pelkonen
Olavi Pelkonen
Khaled AbassKhaled Abass
Khaled Abass
JWJacqueline Wiesner
Jacqueline Wiesner

1 January 2022 in Environmental Health Perspectives
Verified
Journal Article
Closed access
KSKam Sripada
Kam Sripada
AWAneta Wierzbicka
Aneta Wierzbicka
Khaled AbassKhaled Abass
Khaled Abass
Joan GrimaltJoan Grimalt
Joan Grimalt
AEAndreas Erbe
Andreas Erbe
MWMartin Wagner
Martin Wagner

1 March 2012 in Toxicology
Verified
Journal Article
Closed access
Khaled AbassKhaled Abass
Khaled Abass
VLVirpi Lämsä
Virpi Lämsä
PRPetri Reponen
Petri Reponen
JKJenni Küblbeck
Jenni Küblbeck
PHPaavo Honkakoski
Paavo Honkakoski
JHJukka Hakkola
Jukka Hakkola

13 July 2009 in Journal of Environmental Science and Health, Part B
Verified
Journal Article
Closed access
Khaled AbassKhaled Abass
Khaled Abass
MTMiia Turpeinen
Miia Turpeinen
OPOlavi Pelkonen
Olavi Pelkonen
The goal of this work was to study the ability of 18 pesticides to inhibit selective model activities for all major xenobiotic-metabolizing enzymes, namely CYP1A1/2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4. Generally organophosphorus insecticides were the most potent and extensive inhibitors, especially towards CYP1A1/2 (IC50 values of chlorpyrifos, fenitrothion and profenofos ∼3 μ M), CYP2B6 (IC50 values of chlorpyrifos and fenitrothion 2.5 μ M), CYP2C8 (fenitrothion 4.3 μ M), CYP2C9 (fenitrothion and malathion 4.8 and 2.5 μ M, respectively), CYP2D6 (chlorpyrifos and phenthoate ∼ 3 μ M) and CYP3A4 (chlorpyrifos, fenitrothion and phenthoate 3–4 μ M). Otherwise there were quite considerable differences in potency and extent of inhibition between different organophosphates. Pyrethroids were in general very weak or inactive. Deltamethrin and fenvalerate were potent inhibitors of CYP2D6 (IC50 values of ∼ 3 μ M) while lambda-cyhalothrin potently inhibited both CYP2D6 and CYP3A4-mediated activities (IC50's about 3–4 μ M). Some pesticides caused relatively potent inhibitions sporadically (carbendazim, CYP2D6, IC50 = 12 μ M; atrazine, CYP3A4, IC50 = 2.8 μ M; glyphosate, CYP2C9, IC50 = 3.7 μ M; hexaflumuron, IC50 = 6.0 μ M). With the exceptions of alpha-cypermethrin, cypermethrin, isoproturon, carbaryl and abamectin, most pesticides inhibited relatively potently at least one CYP-selective activity, which may have relevance for potential interactions in occupational exposures and for further studies on the CYP-associated metabolism of respective pesticides.

27 January 2010 in Xenobiotica
Verified
Journal Article
Closed access
PDF file
DSD. K. Sevior
D. K. Sevior
JHJ. Hokkanen
J. Hokkanen
ATA. Tolonen
A. Tolonen
Khaled AbassKhaled Abass
Khaled Abass
LTL. Tursas
L. Tursas
JAJ. T. Ahokas
J. T. Ahokas
Self-administration of complementary products concurrently with conventional medication is increasingly common. The potential for cytochrome P450 (CYP) inhibition requires investigation. The N-in-one assay with ten probe substrates for nine CYPs was used with human liver microsomes to investigate ten products. CYP inhibition was measured in a single liquid chromatography-tandem mass spectrometry (LC/MS-MS) analysis. Estimated IC50-values were determined for the extracts that produced significant inhibition (less than 100 μg ml−1). Inhibition of CYP2C19 by dong quai (IC50 = 13.7–14.3 μg ml−1 for the methanolic extract) and CYP2D6 by goldenseal (IC50 = 6.7 and 6.3 μg ml−1 for the aqueous and methanolic extracts, respectively), are of particular concern as the potential for adverse interactions is high. The inhibition of CYP2C8 by horsetail (IC50 = 93 μg ml−1 for the aqueous extract) requires further investigation, as the potential for concurrent use with products that require CYP2C8 for metabolism is significant. CYP3A4 inhibition varied depending on the probe reaction being monitored. The earlier reported findings of inhibition by black cohosh, goldenseal and gotu kola were confirmed. The present work has shown that the N-in-one cocktail is a rapid and reliable method that can be used as an initial screen to help prioritize products that require more detailed investigations and it can also be applied to monitor product variability.